Gerard Espinosa
#163,790
Most Influential Person Now
Researcher
Gerard Espinosa's AcademicInfluence.com Rankings
Gerard Espinosaengineering Degrees
Engineering
#7169
World Rank
#8532
Historical Rank
Electrical Engineering
#2216
World Rank
#2322
Historical Rank
Gerard Espinosacomputer-science Degrees
Computer Science
#9647
World Rank
#10124
Historical Rank
Computational Linguistics
#2360
World Rank
#2383
Historical Rank
Machine Learning
#4280
World Rank
#4329
Historical Rank
Artificial Intelligence
#4630
World Rank
#4692
Historical Rank
Download Badge
Engineering Computer Science
Gerard Espinosa's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Gerard Espinosa Influential?
(Suggest an Edit or Addition)Gerard Espinosa's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients (2009) (585)
- Catastrophic Antiphospholipid Syndrome: Clues to the Pathogenesis from a Series of 80 Patients (2001) (404)
- Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients (2008) (306)
- Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults (1998) (302)
- Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. (2006) (293)
- The Catastrophic Antiphospholipid Syndrome (2014) (280)
- Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome (2005) (225)
- Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. (2013) (201)
- Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients (2004) (187)
- Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry. (2016) (186)
- Adrenal Involvement in the Antiphospholipid Syndrome: Clinical and Immunologic Characteristics of 86 Patients (2003) (185)
- 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. (2014) (172)
- Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. (2002) (172)
- Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. (2010) (166)
- Analysis of patient flow in the emergency department and the effect of an extensive reorganisation (2003) (160)
- Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. (2010) (152)
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials (2016) (149)
- Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies (2004) (147)
- The lung in the antiphospholipid syndrome (2002) (146)
- Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. (2007) (145)
- Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". (2006) (139)
- Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. (2010) (138)
- Long term outcome of catastrophic antiphospholipid syndrome survivors (2003) (136)
- The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases. (2015) (128)
- Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. (2006) (123)
- The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. (2007) (118)
- The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review. (2018) (115)
- Tocilizumab treatment for refractory uveitis-related cystoid macular edema (2013) (112)
- Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients. (2010) (107)
- Etiopathogenesis of Behcet's disease. (2010) (106)
- Trends in Illicit Drug Emergencies: The Emerging Role of Gamma-Hydroxybutyrate (2002) (105)
- Current treatment of antiphospholipid syndrome: lights and shadows (2015) (104)
- Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization (2015) (103)
- Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. (2015) (103)
- Clinical study and follow-up of 100 patients withthe antiphospholipid syndrome (1999) (102)
- A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. (2013) (99)
- Young Onset of Primary Sjögren's syndrome: clinical and immunological characteristics (1998) (99)
- Budd-Chiari Syndrome Secondary to Antiphospholipid Syndrome: Clinical and Immunologic Characteristics of 43 Patients (2001) (96)
- The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. (1995) (96)
- Hepatitis C virus infection in ‘primary’ Sjögren’s syndrome: prevalence and clinical significance in a series of 90 patients (1997) (95)
- Immunosuppression and Chagas Disease: A Management Challenge (2013) (95)
- Management of the antiphospholipid syndrome (2010) (95)
- Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases (2007) (92)
- Adalimumab for the treatment of Behçet's disease: experience in 19 patients. (2012) (89)
- Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients (2005) (89)
- Sedation for cardioversion in the emergency department: analysis of effectiveness in four protocols. (2003) (87)
- Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions (2011) (85)
- Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis (2010) (85)
- Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. (2006) (84)
- Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations (2011) (82)
- Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features. (2013) (78)
- McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome (2018) (78)
- Antiphospholipid syndrome: pathogenic mechanisms. (2003) (78)
- Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. (2005) (78)
- Management of refractory cases of catastrophic antiphospholipid syndrome. (2011) (77)
- Update on the Catastrophic Antiphospholipid Syndrome and the “CAPS Registry” (2012) (77)
- Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). (2014) (75)
- Relapsing catastrophic antiphospholipid syndrome: report of three cases. (2008) (74)
- The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients (2005) (74)
- A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with Systemic Sclerosis in a large European cohort (2010) (73)
- Catastrophic antiphospholipid syndrome and sepsis. A common link? (2007) (73)
- Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry". (2014) (73)
- The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. (2000) (71)
- TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA (2017) (69)
- Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. (1999) (69)
- Behçet Disease-associated Uveitis Successfully Treated with Golimumab (2013) (68)
- Factors influencing polyautoimmunity in systemic lupus erythematosus. (2010) (66)
- Epidemiology and management of refractory lupus nephritis. (2011) (64)
- Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature. (2011) (64)
- Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases (2020) (63)
- Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study (2012) (62)
- Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center. (2016) (62)
- Myelodysplastic and Myeloproliferative Syndromes Associated with Giant Cell Arteritis and Polymyalgia Rheumatica: A Coincidental Coexistence or a Causal Relationship? (2002) (60)
- Cardiac toxicity secondary to long term treatment with chloroquine (2001) (60)
- Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment. (2002) (59)
- Effects of external and internal factors on emergency department overcrowding. (2002) (59)
- Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. (2007) (59)
- Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors. (2008) (59)
- Antiphospholipid syndrome: frequency, main causes and risk factors of mortality (2010) (58)
- Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. (2005) (57)
- Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients. (1997) (56)
- Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity (2013) (56)
- The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients (2018) (54)
- The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients (2018) (54)
- Diagnosis and treatment of lupus nephritis. Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish Society of Internal Medicine (SEMI) and Spanish Society of Nephrology (S.E.N.). (2012) (54)
- Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. (1997) (54)
- Fluencia verbal en niños españoles en edad escolar: estudio normativo piloto y análisis de las estrategias organizativas (2008) (53)
- Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case–control study (2011) (52)
- The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome (2009) (52)
- Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. (2000) (52)
- The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. (2019) (52)
- Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative (2013) (50)
- Adrenal involvement in the antiphospholipid syndrome (2003) (49)
- Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases. (2010) (49)
- Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent (2007) (48)
- Catastrophic APS in the Context of Other Thrombotic Microangiopathies (2015) (48)
- Peripheral nervous system involvement in systemic lupus erythematosus: Prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre. (2017) (47)
- Amputation of digits or limbs in patients with antiphospholipid syndrome. (2008) (47)
- Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci (2016) (46)
- Effects of infliximab in the treatment of refractory posterior uveitis of Behçet’s disease after withdrawal of infusions (2010) (45)
- Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis. (2001) (45)
- Catastrophic Antiphospholipid Syndrome: Treatment, Prognosis, and the Risk of Relapse (2009) (44)
- Identification of a natural soluble form of human CD5. (1999) (44)
- Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis (2001) (44)
- Early- versus Late-Onset Systemic Sclerosis (2014) (44)
- Current and future treatments for Behçet’s uveitis: road to remission (2014) (43)
- Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients (2007) (43)
- A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome (2021) (41)
- Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus (2007) (41)
- Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis (2012) (40)
- Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry. (2020) (40)
- Cardiac valve replacement in patients with antiphospholipid syndrome (2012) (39)
- Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus (2011) (39)
- A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis (2012) (38)
- Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis. (2020) (38)
- Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide (2020) (37)
- ADAMTS-13 in Critically Ill Patients With Septic Syndromes and Noninfectious Systemic Inflammatory Response Syndrome (2015) (37)
- Allelic Diversity and Affinity Variants of MICA are Imbalanced in Spanish Patients with Behçet's Disease (2006) (37)
- Saturación del servicio de urgencias: factores asociados y cuantificación (2003) (37)
- HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population (2013) (37)
- Catastrophic antiphospholipid syndrome: The current management approach. (2016) (35)
- Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility (2012) (35)
- Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study. (2012) (34)
- Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population. (2011) (34)
- Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease. (2013) (33)
- Auscultation of Velcro Crackles is Associated With Usual Interstitial Pneumonia (2016) (33)
- Catastrophic antiphospholipid syndrome: an update. (2017) (32)
- Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry. (2006) (32)
- Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis. (2013) (32)
- Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever. (2015) (32)
- Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses. (2013) (32)
- Solid cancer, antiphospholipid antibodies, and venous thromboembolism. (2011) (32)
- Diagnóstico y tratamiento de la nefritis lúpica Documento de consenso del Grupo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Sociedad Española de Medicina Interna (SEMI) y de la Sociedad Española de Nefrología (S.E.N.) (2012) (31)
- Epistatic Interaction of ERAP1 and HLA-B in Behçet Disease: A Replication Study in the Spanish Population (2014) (31)
- Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome. (2006) (31)
- Lessons from the "Euro-Lupus Cohort". (2002) (31)
- Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis. (2017) (30)
- Advanced MRI techniques: biomarkers in neuropsychiatric lupus (2017) (29)
- Cardiac tamponade and severe pericardial effusion in systemic sclerosis: report of nine patients and review of the literature (2017) (29)
- Gastrointestinal-associated autoantibodies in different autoimmune diseases. (2012) (29)
- Programa de Reanimación cardiopulmonar Orientado a Centros de Enseñanza Secundaria (PROCES): análisis de los resultados del estudio piloto (2005) (28)
- Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus (2002) (28)
- High Prevalence of Prothrombotic Abnormalities in Multifocal Osteonecrosis (2013) (28)
- Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels (2009) (28)
- Delayed lupus nephritis (2008) (28)
- Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship? (2005) (28)
- Proinflammatory Cytokines and C-Reactive Protein in Uveitis Associated with Behçet's Disease (2014) (28)
- Mutational profile of rare variants in inflammasome-related genes in Behçet disease: A Next Generation Sequencing approach (2017) (28)
- Intoxicación por éxtasis líquido: estudio de 22 casos (2001) (26)
- First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study (2018) (26)
- Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort (2018) (26)
- Renal Transplantation in Systemic Lupus Erythematosus: Outcome and Prognostic Factors in 50 Cases from a Single Centre (2014) (26)
- International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies (2016) (26)
- Epidemiology and clinical outcomes of bloodstream infections among lupus patients (2011) (26)
- Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis. (2019) (25)
- Causes and factors related to hospitalizations in patients with systemic lupus erythematosus: analysis of a 20-year period (1995–2015) from a single referral centre in Catalonia (2019) (25)
- Belimumab, a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus. (2010) (25)
- Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy. (2013) (25)
- Catastrophic Antiphospholipid Syndrome (2007) (24)
- Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis (2011) (23)
- The role of malignancies in patients with catastrophic anti-phospholipid (Asherson’s) syndrome (2007) (23)
- Registry of the Spanish network of Behçet's disease: a descriptive analysis of 496 patients. (2014) (23)
- Optic neuropathy in the “primary” antiphospholipid syndrome: Report of a case and review of the literature (1997) (23)
- "Non-criteria" antiphospholipid syndrome: A nomenclature proposal. (2020) (22)
- Effectiveness of Thrombopoietin-receptor Agonists in the Treatment of Refractory Immune Thrombocytopenia Associated to Systemic Lupus Erythematosus (2014) (22)
- Effectiveness and safety of belimumab in patients with systemic lupus erythematosus in a real-world setting (2019) (22)
- Effects of β2‐glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions (2002) (21)
- The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis (2011) (21)
- Eficacia y seguridad de rituximab en el tratamiento del síndrome antifosfolipídico primario: análisis de 24 casos a partir de la revisión de la bibliografía (2015) (21)
- Characterization of isolated retinal vasculitis. Analysis of a cohort from a single center and literature review. (2017) (21)
- Anti‐MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy (2014) (20)
- Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome (2015) (20)
- First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort (2016) (20)
- Val247Leu β2-glycoprotein-I allelic variant is associated with antiphospholipid syndrome: systematic review and meta-analysis. (2012) (20)
- A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center (2020) (20)
- Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies. (2017) (20)
- COVID-19 and Behçet’s disease: clinical case series (2020) (19)
- Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome. (2006) (19)
- Variants of the IFI16 Gene Affecting the Levels of Expression of mRNA Are Associated with Susceptibility to Behçet Disease (2015) (19)
- GIMAP and Behçet disease: no association in the European population (2014) (19)
- [Diagnosis and treatment of lupus nephritis]. (2012) (18)
- Standardization procedure for flow cytometry data harmonization in prospective multicenter studies (2020) (17)
- Morbidity and mortality in the antiphospholipid syndrome (2009) (17)
- Derivación sin visita desde los servicios de urgencias hospitalarios: cuantificación, riesgos y grado de satisfacción (2006) (17)
- Lymphoplasmacytic lymphoma causing light chain cast nephropathy. (2012) (17)
- Diagnóstico y tratamiento de la nefritis lúpica (2012) (17)
- The 4G/4G genotype of the 4G/5G polymorphism of the type‐1 plasminogen activator inhibitor (PAI‐1) gene is a determinant of penetrating behaviour in patients with Crohn's disease (2003) (17)
- Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE). (2017) (17)
- Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome? (2013) (16)
- Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI) (2020) (16)
- Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo? (2008) (16)
- Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease (2019) (16)
- Congenital heart block related to maternal autoantibodies: descriptive analysis of a series of 18 cases from a single center (2016) (16)
- Treat-to-target in systemic lupus erythematosus: Where are we? (2020) (15)
- [Basic cardiopulmonary resuscitation program for high school students (PROCES). Results from the pilot program]. (2004) (15)
- Antiphospholipid syndrome (2008) (15)
- Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies. (2010) (15)
- [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients]. (1997) (15)
- The Rheumatology Drugs for COVID-19 Management: Which and When? (2021) (15)
- Quality and effectiveness of an emergency department during weekends (2004) (15)
- Evaluación del impacto en la calidad asistencial y análisis coste-efectividad de la reforma de un servicio de urgencias de medicina (2001) (15)
- Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis. (2015) (14)
- Antiphospholipid syndrome during pegylated interferon alpha-2a therapy for chronic hepatitis C. (2009) (14)
- Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion? (2017) (14)
- A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020) (14)
- Catastrophic antiphospholipid syndrome triggered by fulminant disseminated herpes simplex infection in a patient with systemic lupus erythematosus (2012) (14)
- Antiphospholipid Antibodies: From General Concepts to Its Relation with Malignancies (2016) (14)
- Repeated Renal Biopsy - A Predictive Tool to Assess the Probability of Renal Flare in Lupus Nephritis (2016) (14)
- Genotypes Coding for Low Serum Levels of Mannose-Binding Lectin Are Underrepresented among Individuals Suffering from Noninfectious Systemic Inflammatory Response Syndrome (2009) (13)
- Caracterización de los pacientes con uveítis remitidos a una unidad multidisciplinar de referencia en el norte de España (2017) (13)
- Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study (2020) (13)
- Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry". (2022) (13)
- Inherited thrombophilia in women with poor aPL‐related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort (2016) (13)
- Beta‐2‐Glycoprotein‐I Deficiency Could Precipitate an Antiphospholipid Syndrome‐like Prothrombotic Situation in Patients With Coronavirus Disease 2019 (2021) (13)
- Behçet’s disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes (2019) (13)
- Venous thromboembolic disease in systemic autoimmune diseases: an association to keep in mind. (2012) (13)
- Thromboprophylaxis and obstetric management of the antiphospholipid syndrome (2009) (13)
- Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: Analysis of 24 cases from the bibliography review (2015) (13)
- Association of haplotypes of the TLR8 locus with susceptibility to Crohn's and Behçet's diseases. (2015) (12)
- Venous thrombosis and relapses in patients with Behçet's disease. Descriptive analysis from Spanish network of Behçet's disease (REGEB cohort). (2018) (12)
- Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review. (2020) (12)
- Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center (2020) (12)
- [Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review]. (2015) (11)
- Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge (2022) (11)
- Kinetic analysis of changes in T- and B-lymphocytes after anti-CD20 treatment in renal pathology. (2017) (11)
- The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome. (2018) (11)
- Case Report : Successful Treatment with Posaconazole of a Patient with Chronic Chagas Disease and Systemic Lupus Erythematosus (2010) (11)
- Treatment for refractory lupus nephritis: Rituximab vs triple target therapy. (2019) (11)
- Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis (2012) (11)
- Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus. (2016) (11)
- Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus (2015) (11)
- Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation. (2020) (11)
- Pars Plana Vitrectomy for Vitreoretinal Complications of Behçet Uveitis (2013) (10)
- Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature (2021) (10)
- ORIGINAL ARTICLE: Thrombin Activatable Fibrinolysis Inhibitor and Clot Lysis Time in Pregnant Patients with Antiphospholipid Syndrome: Relationship with Pregnancy Outcome and Thrombosis (2009) (10)
- Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy. (2006) (10)
- Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis (2017) (10)
- El pulmón en el síndrome antifosfolipídico (2002) (10)
- Procoagulant microparticles are increased in patients with Behçet’s disease but do not define a specific subset of clinical manifestations (2016) (10)
- Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil. (2009) (10)
- Eficacia de la ciclofosfamida endovenosa en el tratamiento de la enfermedad pulmonar intersticial asociada a la esclerosis sistémica (2011) (10)
- Conducta de anidación de la tortuga verde ( Chelonia mydas ) en las playas Antonio y Caleta de Los Piojos de la Península de Guanahacabibes, Pinar del Río, Cuba (2003) (10)
- Catastrophic antiphospholipid syndrome: an orchestra with several musicians. (2014) (10)
- A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases (2021) (9)
- The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis (2021) (9)
- The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis. (2019) (9)
- [Liquid ecstasy poisoning: study of 22 cases]. (2001) (9)
- Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios. (2021) (9)
- The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia (2021) (9)
- Association between allelic variants of the human glucocorticoid receptor gene and autoimmune diseases: A systematic review and meta-analysis. (2018) (8)
- IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases (2020) (8)
- Impact of a systematic evaluation of connective tissue disease on diagnosis approach in patients with interstitial lung diseases (2020) (8)
- Vascular involvement in Behçet's disease. (2002) (8)
- Mechanisms of thrombosis in the antiphospholipid syndrome (2003) (8)
- Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice. (2020) (8)
- [Severe Plasmodium falciparum malaria. Description of 5 cases]. (1997) (8)
- Recambio plasmático en las enfermedades autoinmunes sistémicas (2013) (8)
- Catastrophic antiphospholipid syndrome - 20 years later. (2013) (8)
- Histología gonadal y criterios fenotípicos de maduración en las tortugas marinas Chelonia mydas y Eretmochelys imbricata (Testudines: Chelonidae) de Cuba (2009) (7)
- The problems and pitfalls in systemic lupus erythematosus drug discovery (2016) (7)
- Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study (2022) (7)
- Economic Analysis of the Use of Anti-DFS70 Antibody Test in Patients with Undifferentiated Systemic Autoimmune Disease Symptoms (2019) (7)
- Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies (2010) (7)
- Complications and visual acuity of patients with uveitis: Epidemiological study in a reference unit in northern Spain. (2019) (7)
- Connective tissue diseases: Classification criteria for SLE: the latest—but not least—attempt (2012) (7)
- Endogenous thrombin potential in Behçet's disease: relationship with thrombosis and anticoagulant therapy. (2014) (7)
- Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis (2007) (7)
- SYSTEMIC LUPUS ERYTHEMATOSUS: PATHOGENESIS, CLINICAL MANIFESTATIONS AND DIAGNOSIS (2009) (7)
- Renal tubular acidosis type IV as a complication of lupus nephritis (2016) (6)
- Recent trends in the management of antiphospholipid syndrome (Hughes syndrome). (2010) (6)
- Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection (2022) (6)
- Treatment recommendations for non-infectious anterior uveitis. (2017) (6)
- Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology (2021) (6)
- Efficacy of cyclophospamide in the treatment of interstitial lung disease associated with systemic sclerosis. (2011) (6)
- Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk (2021) (6)
- Variabilidad genética de Loci microsatélites en los primeros lotes de Litopenaeus vannamei introducidos en Cuba para la Acuicultura (2006) (6)
- Plasma exchange in catastrophic antiphospholipid syndrome. (2019) (6)
- Assessing and Counteracting Fibrosis is a Cornerstone of the Treatment of CKD Secondary to Systemic and Renal Limited Autoimmune Disorders: (2021) (6)
- Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort (2020) (6)
- Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines (2021) (6)
- Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparison. (2020) (6)
- Documento de recomendaciones de tratamiento de la uveítis anterior no infecciosa (2017) (6)
- Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome (2022) (6)
- Repeated Renal Biopsy - A Predictive Tool to Assess the Probability of Renal Flare in Lupus Nephritis. (2016) (6)
- Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions. (2002) (6)
- Chapter 8 Systemic Manifestations of the Antiphospholipid Syndrome (2009) (5)
- Chronic thromboembolic pulmonary hypertension in Behçet's disease: effectiveness of endarterectomy. (2010) (5)
- Profile of patients with uveitis referred to a multidisciplinary unit in northern Spain. (2017) (5)
- Clinical characteristics during diagnosis of a prospective cohort of patients with systemic lupus erythematosus treated in Spanish Departments of Internal Medicine: The RELES study. (2017) (5)
- Thromboprophylaxis and obstetric management of the antiphospholipid syndrome. (2009) (5)
- Evaluación del estado trófico de las aguas oceánicas adyacentes al sur de Cuba a partir Evaluación del estado trófico de las aguas oceánicas adyacentes al sur de Cuba a partir de indicadores microbiológicos y fitoplanctónicos. (2007) (5)
- Autoantibodies, elevated cytokines, and neurocognitive abnormalities in offspring of women with systemic lupus erythematosus: comparison with healthy controls (2019) (5)
- Next stop in the treatment of refractory systemic lupus erythematosus: B-cell targeted combined therapy (2020) (5)
- Usefulness of high‐frequency ultrasonography in the evaluation and monitoring of sclerosing dermatoses: a cohort study (2021) (5)
- Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome (2010) (5)
- Development and implementation of the AIDA International Registry for patients with Behçet’s disease (2022) (5)
- Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses (2020) (5)
- Current management of catastrophic antiphospholipid syndrome (2011) (5)
- Oxigenador extracorpóreo de membrana eficaz en una paciente con miocarditis lúpica fulminante (2017) (5)
- LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients (2019) (5)
- Pregnancy Control in Patients with Systemic Lupus Erythematosus/Antiphospholipid Syndrome: Part 2: Pregnancy Follow-Up. (2019) (5)
- Complicaciones y agudeza visual en los pacientes con uveítis en una unidad multidisciplinar de referencia del norte de España (2019) (5)
- No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis. (2012) (4)
- Relaciones entre cuatro especies de peces de la familia Gerreidae sobre la base de 9 loci electroforéticos (1993) (4)
- Papel de los fármacos biológicos en el tratamiento de las enfermedades autoinmunitarias (2007) (4)
- Variabilidad y distancia genetica en especies de penaeus (1994) (4)
- Control del embarazo en pacientes con lupus eritematoso sistémico/síndrome antifosfolípido. parte 2: seguimiento del embarazo (2019) (4)
- Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus (2015) (4)
- Clinical Management of Antiphospholipid Syndrome-Related Thrombosis (2010) (4)
- Management of Pregnancy in Patients with Systemic Lupus Erythematosus/Antiphospholipid Syndrome. Part 3: Childbirth. Puerperium. Breastfeeding Contraception. Newborn. (2019) (4)
- Scleritis and sclerokeratitis associated with IgA vasculitis: A case series (2021) (4)
- Diagnosis and Management in Pregnancy (2013) (4)
- Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus. (2020) (4)
- Pregnancy Control in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Part 1: Infertility, Ovarian Preservation and Preconception Assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and t (2019) (4)
- Recommendations statement on the immunosuppressive treatment of non-infectious, non-neoplastic, non-anterior uveitis. (2020) (4)
- PTPN22 is not associated with Behçet's disease. Study spanning the complete gene region in the Spanish population and meta-analysis of the functional variant R620W. (2016) (4)
- SYSTEMIC LUPUS ERYTHEMATOSUS : PATHOGENESIS , CLINICAL MANIFESTATIONS AND DIAGNOSIS IN-DEPTH DISCUSSION II Atherosclerosis in systemic lupus erythematosus (2008) (4)
- COVID-19 and the antiphospholipid syndrome (2022) (4)
- [Emergency department overcrowding: quantification of associated factors]. (2003) (4)
- Lack of association of TNFAIP3 and JAK1 with Behçet's disease in the European population. (2015) (4)
- What is the best strategy in treating catastrophic antiphospholipid syndrome (2015) (4)
- Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy (2022) (4)
- [Direct discharge from triage in emergency departments: assessment, risks and patient satisfaction]. (2005) (4)
- Bleeding and antithrombotic therapy during pregnancy in women with poor aPL-related obstetric outcomes (2021) (4)
- Brain abscess due to Listeria monocytogenes after HELLP syndrome in a patient with antiphospholipid syndrome (2017) (4)
- Autologous Hematopoietic Stem Cell Transplantation for Susac Syndrome (2020) (4)
- Detección de cambios conformacionales y mutaciones en el exón 8 del gen atp7b en pacientes cubanos con la enfermedad de Wilson (2011) (4)
- Asociación de síndrome de Sjögren, tiroiditis autoinmune, sarcoidosis, cirrosis biliar primaria y amiloidosis primaria en una misma paciente (2007) (4)
- Definition and Epidemiology of Antiphospholipid Syndrome (2017) (3)
- Síndrome de apneas obstructivas durante el sueño (SAOS) secundario a un linfoma faríngeo. Mejoría con tratamiento con presión continua de la vía aérea superior (CPAP) (1996) (3)
- The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study (2022) (3)
- Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvement. (2020) (3)
- Enfermedad de Behçet (2006) (3)
- Detection of conformational shifts and mutations in exon 8 from the atp7b gene in Cuban Wilson’s disease patients (2011) (3)
- Anti–Polymyositis/Scl Antibodies in Systemic Sclerosis (2021) (3)
- [Role of biologic therapy in systemic autoimmune diseases]. (2007) (3)
- AB0678 Peripheral ulcerative keratitis associated to autoimmune systemic diseases: visual prognosis and occurrence while systemic disease in remission (2018) (3)
- Treatment of ANCA-Associated Vasculitis. Authors' reply (2007) (3)
- Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus (2020) (3)
- Lupus around the world. (2007) (3)
- Successful Extracorporeal Membrane Oxygenation in a Patient With Fulminant Lupus Myocarditis. (2017) (3)
- Reduced ADAMTS 13 activity is associated with thrombotic risk in systemic lupus erythematosus (2015) (3)
- Efficacy of Cyclophosphamide in the Treatment of Interstitial Lung Disease Associated with Systemic Sclerosis (2011) (3)
- [The lung in antiphospholipid syndrome]. (2002) (3)
- [Hydroxychloroquine in the treatment of COVID-19: how to use it waiting for conclusive scientific evidence]. (2020) (3)
- Machine Learning for the Identification of a Common Signature for Anti–SSA/Ro 60 Antibody Expression Across Autoimmune Diseases (2022) (3)
- [Impact in the quality of health care and cost-effectiveness analysis of the reform of an emergency medicine service]. (2001) (3)
- Pulmonary Involvement in the Antiphospholipid Syndrome (2004) (3)
- Síndrome febril sin foco. Prevalencia, etiología y factores predictivos de bacteriemia (1999) (3)
- Características clínicas al diagnóstico de una cohorte prospectiva de pacientes con lupus eritematoso sistémico atendidos en servicios de Medicina Interna españoles: estudio RELES (2017) (3)
- Limitada variabilidad genética de la quinta introducción en Cuba de Litopenaeus vannamei estimada con el uso de marcadores microsatélites (2011) (3)
- Hematological Abnormalities in the Antiphospholipid Syndrome (2010) (3)
- Successful treatment of two cases of refractory cutaneous lupus erythematosus with belimumab. (2021) (2)
- Clinico-pathological phenotypes of Systemic Sclerosis associated myopathy: analysis of a multicenter large cohort. (2022) (2)
- A new molecular classi fi cation to drive precision treatment strategies in primary Sjögren ’ s syndrome (2021) (2)
- Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 2: Pregnancy follow-up (2020) (2)
- Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey (2021) (2)
- Precision medicine and the antiphospholipid syndrome: what is the future? (2020) (2)
- Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: result of the COVID-19-GEAS patient survey. (2021) (2)
- Mortality prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit (2013) (2)
- Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 3: Childbirth. Puerperium. Breastfeeding contraception. Newborn (2021) (2)
- Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines. (2022) (2)
- [Diagnosis and treatment of lupus nephritis: the way to consensus]. (2012) (2)
- All that glitters is not lupus (2018) (2)
- Anti-TNF-alpha-induced lupus in patients with non-infectious uveitis (2021) (2)
- Obstetric outcomes in systemic sclerosis: looking inside the sealed box (2021) (2)
- Estructura genética de poblaciones de Caretta careta en el Gran Caribe y la costa atlántica occidental empleando un fragmento de la región no codificadora del mtDNA, con énfasis en colonias de anidación del suroeste cubano. (2011) (2)
- Estudio del polimorfismo proteico y del DNA mitocondrial en la tortuga carey Eretmochelys imbricata (1999) (2)
- Terapias biológicas en el lupus eritematoso sistémico (2010) (2)
- Antimalarial-induced retinal toxicity (2021) (2)
- Hidroxicloroquina en el tratamiento del COVID-19: cómo utilizarla a la espera de evidencia científica concluyente (2020) (2)
- Proposed Guidelines for Diagnosis and Treatment (2002) (2)
- Miocardiopatía aguda como manifestación clínica de esclerosis sistémica (2011) (2)
- Enfermedades autoinmunes y vacunas contra la COVID-19. Toma de decisiones en escenarios de incertidumbre (2021) (2)
- Unilateral granulomatous mastitis in a pregnant woman as a first manifestation of sarcoidosis (2021) (2)
- Multidisciplinary care and units for uveitis in the internal medicine departments in Spain: Survey of the Systemic Autoimmune Diseases Group. (2020) (2)
- SAT0215 APREMILAST IN REFRACTORY ORAL AND/OR GENITAL ULCERS IN BEHÇET’S DISEASE. MULTICENTER STUDY OF 49 CASES IN CLINICAL PRACTICE (2019) (2)
- Belimumab in SLE (2012) (2)
- The anti-phospholipid syndrome: 30 years in the forefront (1983-2013). (2013) (1)
- Original Article Gastrointestinal-associated autoantibodies in different autoimmune diseases (2012) (1)
- Papel etiopatogénico del virus de la hepatitis C en el síndrome antifosfolípidico (2000) (1)
- [The etiopathogenic role of hepatitis virus C in the antiphospholipid syndrome]. (2000) (1)
- Estudio genético-bioquímico de la población de Penaeus notialis de la Ensenada de la Broa (1996) (1)
- Los valores persistentemente positivos de anticuerpos antifosfolipídicos están relacionados con la aparición de trombosis durante el seguimiento de pacientes con síndrome antifosfolipídico (2007) (1)
- Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis (2022) (1)
- Task Force Report on Catastrophic Antiphospholipid Syndrome (2012) (1)
- Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis (2022) (1)
- FRI0213 Anti-TNF therapy in refractory uveitis of behcet’s syndrome. A multicenter study of 63 patients (2013) (1)
- Primary and secondary glomerulonephritis I (2012) (1)
- AB0630 Assessment of organ damage accrual in Behçet's Syndrome over 2-year follow-up: results from the BODI Project longitudinal extension. (2022) (1)
- Longitudinally extensive myelitis in a patient with characteristic autoantibody profile of systemic lupus erythematosus: a challenging etiological diagnosis (2014) (1)
- Why lupus patients discontinue antimalarials in real life: A 50 years-experience from a reference centre (2022) (1)
- [Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: result of the COVID-19-GEAS patient survey]. (2021) (1)
- COVID-19 coagulopathy and antiphospholipid syndrome (2021) (1)
- Síndrome antifosfolipídico: análisis de 27 casos (2013) (1)
- Understanding tubulointerstitial injury and repair mechanisms paves the way for renal outcome improvement in lupus nephritis (2021) (1)
- Gastrointestinal Involvement in Dermatomyositis (2022) (1)
- FRI0418 Outcome of the Autoimmune Congenital Heart Block in 45 Babies from Anti-RO/LA (+) Mothers: Results from the Spanish Registry (Rebacc-Geas-Semi) (2015) (1)
- THU0561 Clinical practice guideline for diagnosis and management of catastrophic antiphospholipid syndrome (2017) (1)
- prospective study of 1,000 patients syndrome during a 5-year period: a multicenter Morbidity and mortality in the antiphospholipid (2009) (1)
- Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies (2018) (1)
- Placental damage in pregnancies with systemic lupus erythematosus: A narrative review (2022) (1)
- Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy (2020) (1)
- Non-criteria Manifestations of Antiphospholipid Syndrome: An Overview (2021) (1)
- Identification of indoor fungal antigens in assessment of hypersensitivity pneumonitis – an alternate approach (2019) (1)
- O31 Integrative analysis reveals a molecular stratification of systemic autoimmune diseases (2020) (1)
- Chapter 17 - Treatment of Catastrophic Antiphospholipid Syndrome (2017) (1)
- Multicenter study of TNF-a antagonists for refractory Behçet’s uveitis in Spain (2013) (1)
- Association of CCR5Δ32 and Behçet's disease: new data from a case-control study in the Spanish population and meta-analysis. (2015) (1)
- Causes of hospitalization in Systemic Lupus Erythematosus: a narrative review. (2020) (1)
- Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography. (2022) (1)
- Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies. (2020) (1)
- VACOVEAS study, an observational survey on the adverse events associated with COVID-19 vaccines in patients with systemic autoimmune diseases (2021) (1)
- SAT0534 Thrombosis and Re-Thrombosis Manifestations in Patients with Behçet Disease. Descriptive Analysis from Regeb Cohort (2015) (1)
- Treat to target in systemic lupus erythematosus (2021) (1)
- 15th International Congress on Antiphospholipid Antibodies Task Force on Catastrophic Antiphospholipid Syndrome Report (2017) (1)
- Clinical Management of Antiphospholipid Syndrome-Related Thrombosis~!2009-09-14~!2009-09-17~!2010-03-11~! (2010) (1)
- Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios (2021) (1)
- Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence☆ (2020) (1)
- Efecto del lipopolisacárido sobre el número de hemocitos y la producción de óxido nítrico en el camarón blanco (Litopenaeus schmitti) (2002) (1)
- Systemic Lupus Erythematosus : Pathogenesis and (2012) (1)
- Actividad hemoaglutinante de la hemolinfa de Litopenaeus schmitti (2001) (1)
- Thrombotic Manifestations of the Antiphospholipid Syndrome (2017) (1)
- Chapter 4 Antiphospholipid Syndrome (2008) (1)
- Tuberculosis-Related Uveitis in Patients under Anti-TNF-alpha Therapy: A Case Series (2020) (1)
- Patrones de electroforéticos de proteínas durante el desarrollo del camarón blanco Litopenaeus schmitti (2006) (1)
- AB0636 Relationship between organ damage and impairment of health-related quality of life in patients with Behçet’s Syndrome: results from a longitudinal extension of the BODI Project. (2022) (0)
- Formación continuada del médico práctico: Tromboangeítis obliterante (2001) (0)
- Tocilizumab in Behcet's disease: a multicentre study of 30 patients. (2023) (0)
- Thrombotic Microangiopathy: a Challenging Diagnosis Always. (2016) (0)
- Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS) RHEUMATOLOGY (2014) (0)
- Behçet’s disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes (2019) (0)
- POS1409 AUTOMATED DETECTION OF SCLERODERMIFORM PATTERNS USING CAPILLARY.IO (2021) (0)
- Contents Vol. 44, 2016 (2016) (0)
- Chapter 9 Adrenal Involvement in Systemic Autoimmune Diseases (2008) (0)
- FRI0234 BehÇet’s disease: Clinical and immunologic manifestations in a cohort of 377 patients (2013) (0)
- [Rituximab action on the antiphospholipid antibodies in patients with thrombotic antiphospholipid syndrome]. (2016) (0)
- Analysis of central nervous system findings on MR imaging in patients with neurolupus (2013) (0)
- SAT0316 ANTI-PM/SCL ANTIBODIES IN SYSTEMIC SCLEROSIS: CLINICAL ASSOCIATIONS IN THE RESCLE COHORT (2020) (0)
- List of Contributors (2019) (0)
- Patients with laboratory criteria of anti-phospholipid syndrome and ‘non-criteria’ manifestations: a multicenter cohort (2022) (0)
- THU0549 Systemic treatment for acute anterior uveitis (synthetic and biologic disease-modifying antirheumatic drugs): a systematic review (2017) (0)
- The 4G/5G polymorphism of the type-1 plasminogen activator inhibitor gene is a determinant of disease phenotype and thrombotic events in patients with inflammatory bowel disease (2001) (0)
- [Behçet disease]. (2006) (0)
- Diagnosing catastrophic antiphospholipid syndrome: the necessity for clinical awareness (2014) (0)
- Rituximab action on the antiphospholipid antibodies in patients with thrombotic antiphospholipid syndrome (2016) (0)
- Cardiac Involvement in the Antiphospholipid Syndrome (2017) (0)
- No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis. (2011) (0)
- Descriptive study of patients with uveitis attended during one-year period - diagnostic classification and treatment (2010) (0)
- The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the “Catastrophic antiphospholipid syndrome registry” (2022) (0)
- A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020) (0)
- Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center (2022) (0)
- Treatment of Antiphospholipid Syndrome (2011) (0)
- Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome (2022) (0)
- Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study (2022) (0)
- Presumed tuberculosis-related scleritis (2014) (0)
- Identification of Novel Genetic Susceptibility Loci in Primary Antiphospholipid Syndrome (2016) (0)
- FRI0338 Multicenter study of tumour necrosis factor alpha antagonists for refractory behçet’s uveitis in spain (2013) (0)
- POS0767 CLINICAL MANIFESTATIONS, TREATMENT, AND OUTCOMES OF “NON-CRITERIA” ANTIPHOSPHOLIPID SYNDROME IN COMPARISON WITH DEFINITE ANTIPHOSPHOLIPID SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS (2021) (0)
- Late Breaking Abstract - SMOKING PREVALENCE AND CHARACTERIZATION OF PATIENTS AT DIAGNOSIS OF DIFFUSE INTERSTITIAL LUNG DISEASES (2018) (0)
- Treatment of ANCA-Associated Vasculitis—Reply (2007) (0)
- Corrigendum to "Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group" [Placenta. 136 (2023 Apr 3) 29-34]. (2023) (0)
- Corrigendum to: Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from EUROAPS registry. (2021) (0)
- Complications and visual acuity of patients with uveitis: Epidemiological study in a reference unit in northern Spain (2019) (0)
- SAT0274 DESCRIPTIVE ANALYSIS OF FLARES DURING THE LONG-TERM FOLLOW-UP OF PATIENTS WITH BEHÇET’S DISEASE INCLUDED IN REGEB COHORT (2020) (0)
- Bipolar disorder and Susac syndrome: a case report (2021) (0)
- Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities? (2020) (0)
- AB0009 The HLA Class I Region in Behçet's Disease: Identifying the Most Relevant Amino Acid Positions (2015) (0)
- THU0299 PATIENT GLOBAL ASSESSMENT OF DISEASE ACTIVITY IN BEHÇET’S SYNDROME: A MULTICENTER STUDY (2019) (0)
- OP-BRHE130151 1347..1348 (2013) (0)
- Heart Valve Involvement in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Study of a Single Centre (2023) (0)
- Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review (2022) (0)
- Systemic sclerosis and pregnancy outcomes: a retrospective study from a single centre (2021) (0)
- [Biological therapies in systemic lupus erythematosus]. (2010) (0)
- Thromboprophylaxisand obstetricmanagementofthe antiphospholipidsyndrome (2009) (0)
- Prevalence of gastrointestinal associated autoantibodies in autoimmune diseases as compare to controls (2012) (0)
- THU0327 The Spectrum of Inflammatory Ocular Involvement in Systemic Lupus Erythematosus in a Multidisciplinary Uveitis Unit (2013) (0)
- Document of treatment recommendations for non-infectious anterior uveitis (2017) (0)
- Predictive value of the Adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: A longitudinal study. (2022) (0)
- Musculoskeletal manifestations in children with Behçet’s syndrome: data from the AIDA Network Behçet’s Syndrome Registry (2023) (0)
- FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities (2022) (0)
- POS0256 AUTOMATED CAPILLARY DETECTION AND IMAGE ANALYSIS SOFTWARE IN CAPILLAROSCOPY: CAPILLARY.IO (2021) (0)
- THU0278 Rituximab in Catastrophic Antiphospholipid Syndrome: A Potential Therapeutic Option (2013) (0)
- SP144USEFULNESS OF RENAL BIOPSY ON THE ASSESSMENT OF TREATMENT RESPONSE TO INTRAVENOUS CYCLOPHOSPHAMIDE IN LUPUS NEPHRITIS (2015) (0)
- Severe Cardiac Complications of Shabu Use: An Emerging Drug in Europe (2019) (0)
- Vitrectomy Surgery For Vitreoretinal Complications Of BehçEt's Uveitis (2012) (0)
- Early Infliximab Therapy for Sight-Threatening Posterior Uveitis (2010) (0)
- The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study. (2022) (0)
- SAT0598 Systematic literature review on the efficacy and safety of immunomodulatory drugs in patients with nonifectious intermediate and posterior uveitis, panuveitis and macular oedema (2018) (0)
- Eular On-line Course on Rheumatic Diseases – module n ° 17 (2008) (0)
- Mutational profile of rare variants in inflammasome-related genes in Behçet disease: A Next Generation Sequencing approach (2017) (0)
- Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507]. (2021) (0)
- FRI0270 APREMILAST IN NON-ULCER MANIFESTATIONS IN BEHçET’S DISEASE. MULTICENTER STUDY OF 32 CASES IN CLINICAL PRACTICE (2019) (0)
- Cessation of oral anticoagulants in antiphospholipid syndrome (2017) (0)
- Clinical Manifestations and Diagnosis of Behçet’s Syndrome (2021) (0)
- Susac Syndrome: Description of a Single-Centre Case Series (2022) (0)
- Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group. (2023) (0)
- Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre. (2022) (0)
- Multidisciplinary care and units for uveitis in the internal medicine departments in Spain: Survey of the Systemic Autoimmune Diseases Group. (2020) (0)
- AB0340 PATIENTS WITH LABORATORY CRITERIA OF ANTIPHOSPHOLIPID SYNDROME AND “NON-CRITERIA” MANIFESTATIONS: A MULTICENTER STUDY (2021) (0)
- Pharmacological Treatments for Thrombotic Diseases (2001) (0)
- OP0282 OBSTETRIC ANTIPHOSPHOLIPID SYNDROME (OAPS) VS. WITH OBSTETRIC MORBIDITY RELATED WITH ANTIPHOSPHOLIPID ANTIBODIES (OMAPS): A SURVEY OF 1650 CASES FROM EUROAPS REGISTRY (2019) (0)
- Recurrent dural arteriovenous fistulas in a patient with Behçet's disease. (2017) (0)
- FRI0602 National recommendations on the use of immunomodulatory drugs in patients with non-infectious non-malignant anterior uveitis (2017) (0)
- AB0214 MUSCLE INVOLVEMENT IN SYSTEMIC SCLEROSIS (2019) (0)
- Lung involvement in SLE (2022) (0)
- Digestive Involvement in the Antiphospholipid Syndrome (2017) (0)
- Correction: Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity (2014) (0)
- [Association of Sjögren syndrome, autoimmune thyroiditis, sarcoidosis, primary biliary cirrhosis and primary amyloidosis in a single patient]. (2007) (0)
- Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative (2013) (0)
- IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases (2020) (0)
- Serological autoimmune profile of systemic lupus erythematosus in deep and non-deep endometriosis patients. (2023) (0)
- THU0573 COMPLICATIONS AND ACTIVITY OF UVEITIS IN A MULTIDISCIPLINARY REFERENCE UNIT IN THE NORTH OF SPAIN (2019) (0)
- Prognosis in Antiphospholipid Syndrome (2017) (0)
- Anti-dsDNA B-Cell ELISpot as a Monitoring and Flare Prediction Tool in SLE Patients (2023) (0)
- Editorial to article: "Clinico-pathologic relationship in Colombian patients with lupus nephritis" (2017) (0)
- Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment (2022) (0)
- Heart Valve Surgery and the Antiphospholipid Syndrome (2013) (0)
- SAT0240 DEVELOPMENT AND PRELIMINARY VALIDATION OF THE BEHÇET’S SYNDROME OVERALL DAMAGE INDEX (BODI) (2019) (0)
- AB0631 Anti-Rna Polymerase III and anti Pm/Scl Antibodies: Prevalence and Clinical Associations in A Large Cohort of Spanish Patients with Systemic Sclerosis (2014) (0)
- [Antiphospholipid syndrome: analysis of 27 patients]. (2013) (0)
- Congenital heart block related with maternal autoimmune diseases: Descriptive analysis of a series of 17 cases (2013) (0)
- FRI0487 APREMILAST IN MONOTHERAPY OR COMBINED IN NON-ULCER MANIFESTATIONS OF BEHÇET’S DISEASE. NATIONAL MULTICENTER STUDY OF 34 REFRACTORY CASES OF CLINICAL PRACTICE (2020) (0)
- Association of CCR 5 Δ 32 and Behçet ’ s disease : new data from a case-control study in the Spanish population and meta-analysis (2015) (0)
- OP0231 The effect of “triple therapy” with anticoagulation plus corticosteroids plus plasma exchange and/or intravenous immunoglobulins on the mortality of catastrophic antiphospholipid syndrome (CAPS) patients (2017) (0)
- Task Force Report on Non-criteria Manifestations: Cardiac Valve Disease (2012) (0)
- Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (0)
- Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus (2011) (0)
- External clinical validation of automated software to identify structural abnormalities and microhaemorrhages in nailfold videocapillaroscopy images. (2022) (0)
- [Febrile syndrome without focus. Prevalence, etiology, and predictive factors of bacteremia]. (1999) (0)
- SAT0544 Comparing New and Classical Diagnostic Criteria in Behçet Disease (BD) (2015) (0)
- Unidades y asistencia multidisciplinar de uveítis en los servicios de medicina interna en España: encuesta del Grupo de Enfermedades Autoinmunes Sistémicas (2020) (0)
- Defensa y salvaguarda de las artesanías tradicionales y populares. Formas de cooperación para esta defensa (1983) (0)
- Editorial al artículo: «Relación clínico-patológica en pacientes colombianos con nefritis lúpica» (2017) (0)
- Reply (2022) (0)
- Enfermedades autoinmunes y vacunas contra la COVID-19. Toma dedecisiones en escenarios de incertidumbre (2022) (0)
- LA ORGANIZACION MUNICIPAL ECUATORIANA. (2011) (0)
- Protocolo diagnóstico de la afectación neurológica central en conectivopatías y vasculitis (2009) (0)
- Guías de práctica clínica en lupus eritematoso sistémico: importancia de su implementación en los sistemas de salud (2012) (0)
- Respuesta (2018) (0)
- Acción del rituximab sobre los anticuerpos antifosfolipídicos en pacientes con síndrome antifosfolipídico (2016) (0)
- CAPÍTULO 13 – Experiencia en el tratamiento de las uveítis con agentes anti-TNF-α en la Unidad de Uveítis del Hospital Clínic de Barcelona (2012) (0)
- Arteritis de células gigantes con y sin polimialgia reumática (1999) (0)
- Control del embarazo en pacientes con lupus eritematoso sistémico/síndrome antifosfolípido. Parte 3. Parto. Puerperio. Lactancia. Anticoncepción. Recién nacido (0)
- Documento de recomendaciones sobre el tratamiento con inmunodepresores de la uveítis no anterior, no infecciosa, no neoplásica (2020) (0)
- Metodología de dimensionado de un transductor compuesto para aplicaciones de diatermia (1998) (0)
- Impacto de la infección por el nuevo coronavirus en los pacientes con uveítis asociada a una enfermedad autoinmune: resultado de la encuesta COVID-19-GEAS pacientes (2021) (0)
- Reply (2022) (0)
- BUSQUEDA DE MARCADORES MOLECULARES EN NARANJILLA (SOLANUM QUITOENSE MIL), PARA LA RESISTENCIA AL NEMATODO (MELOIDOGNE INCOGNITA) Y FUSARIUM OXYSPORUM (2008) (0)
- Comparación de la especie de Artemia de Cuba con A. franciscana mediante genética bioquímica e intercruzamiento genético (1995) (0)
- Caracterización molecular de la región no codificadora del DNA mitocóndrico en Caretta caretta y Chelonia mydas del suroeste de Cuba: Una perspectiva regional/Molecular characterization of the mitochondrial DNA non coding region in Caretta caretta and Ch (2008) (0)
- Fístulas arteriovenosas durales recurrentes en paciente con enfermedad de Behçet (2017) (0)
- CÉLULAS ESCAMOSAS ATÍPICAS EN MUJERES INDÍGENAS, RESIDENTES EN LA COMARCA NGÖBE-BUGLÉ, REPÚBLICA DE PANAMÁ. 2009-2010. (2010) (0)
- AB0631 Impact of Behçet’s Syndrome on work activity and productivity: results from a sub-analysis of the BODI Project cohort. (2022) (0)
- FRI0315 Congenital heart block in a cohort of pregnant women with anti-ro/ssa and/or anti-la/ssb antibodies. (2013) (0)
- FRI0311 Neuropsychiatric Lupus: Combining Advanced Morphometric Methods, Diffusion Tensor Imaging and Conventional MRI Leads To The Pathways of Brain Abnormalities. Correlation with Clinical and Laboratory Data (2016) (0)
- AB0561 Infections in newly diagnosed spanish patients with systemic lupus erythematosus: data from the reles cohort (2018) (0)
- POS1371 BIOLOGICAL THERAPY IN REFRACTORY NEUROBEHÇET’S DISEASE. MULTICENTER STUDY OF 42 PATIENTS (2021) (0)
- AB0718 Cardiac Tamponade and Severe Pericardial Effusion in Systemic Sclerosis (2015) (0)
- FRI0403 Heart Valvular Involvement in the Antiphospholipid Syndrome. An Echocardiographic Descriptive Study (2015) (0)
- THU0569 Treatments of uveitis in a referral multidisciplinary unit in northern spain (2017) (0)
- P02-021 - Atypical CAPS consequence of novel NLPR3 mutations (2013) (0)
- [Aortic aneurysm and multiple venous thrombosis as initial manifestation of Behçet's disease]. (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gerard Espinosa?
Gerard Espinosa is affiliated with the following schools:
